Evolutionarily stable anti-cancer therapies by autologous cell defection
about
Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancerDynamics of growth factor production in monolayers of cancer cells and evolution of resistance to anticancer therapies.Heterogeneity and proliferation of invasive cancer subclones in game theory models of the Warburg effect.Cooperation between cancer cells.
P2860
Evolutionarily stable anti-cancer therapies by autologous cell defection
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Evolutionarily stable anti-cancer therapies by autologous cell defection
@en
type
label
Evolutionarily stable anti-cancer therapies by autologous cell defection
@en
prefLabel
Evolutionarily stable anti-cancer therapies by autologous cell defection
@en
P2860
P356
P1476
Evolutionarily stable anti-cancer therapies by autologous cell defection
@en
P2093
Marco Archetti
P2860
P304
P356
10.1093/EMPH/EOT014
P577
2013-01-01T00:00:00Z